Patents by Inventor Janice L. Gabrilove

Janice L. Gabrilove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 8273379
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: September 25, 2012
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • PROCESS FOR PRODUCING ARSENIC TRIOXIDE FORMULATIONS AND METHODS FOR TREATING CANCER USING ARSENIC TRIOXIDE OR MELARSOPROL
    Publication number: 20110091573
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: December 21, 2010
    Publication date: April 21, 2011
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Raymond P. Warrell, JR., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 7879364
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: February 1, 2011
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 6982096
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: January 3, 2006
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 6884439
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: April 26, 2005
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 6861076
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: March 1, 2005
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 6855339
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: February 15, 2005
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Human pluripotent hematopoietic colony stimulating factor, method of production and use
    Patent number: 6838549
    Abstract: Highly purified Pluripotent hematopoietic colony-stimulating factor (pluripotent CSF), a glycoprotein (MW 19,600) constitutively produced by human tumor cells has been highly purified from low serum-containing conditioned medium to apparant homogeneity. Pluripotent CSF supports the growth of human mixed colonies (CFU-GEMM), granulocyte-macrophage colonies (CFU-GM), early erythroid colonies (BFU-E) and induces differentiation of human leukemic cells. The specific activity of the purified pluripotent CSF in the CFU-GM assay is 1.5×108 U/mg protein.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: January 4, 2005
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Karl Welte, Erich Platzer, Janice L. Gabrilove, Roland Mertelsmann, Malcolm A. S. Moore
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040151782
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: August 5, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 6770304
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: August 3, 2004
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146583
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146575
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146581
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146568
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146574
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146578
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146571
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146579
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146570
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146577
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove